KH902 fusion protein

01/01/2018 - "To evaluate the therapeutic efficacy of conbercept for the treatment of diabetic macular edema (DME) with different baseline visual acuity. "
08/28/2020 - "Evaluation of the efficacy of Conbercept in the treatment of diabetic macular edema based on OCTA."
08/09/2023 - "Two different initial treatment regimens of Conbercept in diabetic macular edema: 12-month results from a multicenter randomized controlled study."
01/01/2022 - "In cases of refractory macular edema secondary to CRVO, switching to conbercept improves macular thickness and extends interval of injection. "
10/20/2021 - "To compare different types of diabetic macular edema (DME) classified based on optical coherence tomography (OCT) for their responses to Conbercept injection and analyze the factors that affect the treatment responses. "

01/01/2020 - "One-year efficacy of intravitreal conbercept injection for macular oedema secondary to central retinal vein occlusion in Chinese patients."
01/01/2022 - "The subjects were divided into branch retinal vein occlusion (BRVO) and central retinal vein occlusion (CRVO) according to the involved vessel, subsequently the subjects received intravitreal conbercept treatment. "
01/01/2020 - "To evaluate intravitreal conbercept injection for treatment of macular oedema secondary to central retinal vein occlusion (CRVO) in Chinese patients during 1-year follow-up in the real-world setting. "
03/01/2019 - "To evaluate the effectiveness of intravitreal conbercept injection on major and macular branch retinal vein occlusion (BRVO). "
03/01/2019 - "Short-term effect of intravitreal conbercept injection on major and macular branch retinal vein occlusion."

04/01/2023 - "This study aimed to evaluate the effect of pre-operative versus pre-operative plus post-operative intravitreal conbercept (IVC) injection on severe proliferative diabetic retinopathy (PDR). "
01/01/2023 - "SIGNIFICANCE: Patients with proliferative diabetic retinopathy (PDR) regularly receive intravitreal conbercept treatment these days. "
04/30/2021 - "Although conbercept has been used for other diseases associated with new vascular formation, the effect of single-dose conbercept in combination with proliferative diabetic retinopathy (PDR) have not been established. "
01/01/2020 - "Quantification of Diabetic Retinopathy Lesions in DME Patients With Intravitreal Conbercept Treatment Using Deep Learning."
09/01/2019 - "To evaluate the effect of conbercept on the expression of long noncoding RNAs (lncRNAs) and mRNAs in the fibrovascular membranes of proliferative diabetic retinopathy (PDR) patients. "

05/01/2016 - "To evaluate the efficacy of different doses of conbercept in patients with polypoidal choroidal vasculopathy in the AURORA study. "
01/01/2020 - "The Efficacy of Conbercept in Polypoidal Choroidal Vasculopathy: A Systematic Review."
01/01/2018 - "Short-term efficacy of intravitreal conbercept in treatment-naive patients with polypoidal choroidal vasculopathy."
05/01/2023 - "The comparison of two different strategies of intravitreal conbercept for polypoidal choroidal vasculopathy in Chinese patients results from a 48-week randomized phase 4 study: STAR study."
05/01/2023 - "To compare a treat-and-extend (TAE) strategy with a fixed dosing regimen of intravitreal conbercept (IVC) for the management of treatment-naïve polypoidal choroidal vasculopathy (PCV) patients. "

01/01/2018 - "Therapeutic Efficacy of Conbercept for Inflammatory Choroidal Neovascularization."
01/01/2020 - "Purpose: To investigate the long-term efficacy of intravitreal conbercept injection in treating idiopathic choroidal neovascularization (CNV). "
01/01/2020 - "Long-Term Efficacy of Intravitreal Conbercept Injection in the Treatment of Idiopathic Choroidal Neovascularization."
02/06/2023 - "Long-Term Outcomes of High-Dose Conbercept Treatment for Myopic Choroidal Neovascularization and Idiopathic Choroidal Neovascularization."
09/01/2022 - "Successful Use of Conbercept to Treat Choroidal Neovascularization: A Case Report."